Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil
This contribution is an attempt to estimate a range of Pulmonary Arterial Hypertension (PAH) prevalence in Italy using international literature and Italian drug market sales data and to evaluate the budget impact of the introduction of tadalafil among the actual drugs with specific indication for th...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2010-06-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/185 |
| _version_ | 1828837323478925312 |
|---|---|
| author | Luca Guidi Mariano Alejandro Mignini |
| author_facet | Luca Guidi Mariano Alejandro Mignini |
| author_sort | Luca Guidi |
| collection | DOAJ |
| description | This contribution is an attempt to estimate a range of Pulmonary Arterial Hypertension (PAH) prevalence in Italy using international literature and Italian drug market sales data and to evaluate the budget impact of the introduction of tadalafil among the actual drugs with specific indication for this pathology. The final epidemiological figure obtained shows a wide range of prevalence of PAH in Italy (900-3,000 cases). The introduction of tadalafil as PAH treatment should not cause a cost increase for the pharmaceutical budget considering that this new therapy will occupy essentially the patient segment actually treated with sildenafil and that it reduces, in a significant number of patients, the daily cost of PAH therapy through a stable, fixed dose, administration. |
| first_indexed | 2024-12-12T18:38:29Z |
| format | Article |
| id | doaj.art-e33497e8f07c48b29e4047aeeb92b248 |
| institution | Directory Open Access Journal |
| issn | 2240-256X |
| language | English |
| last_indexed | 2024-12-12T18:38:29Z |
| publishDate | 2010-06-01 |
| publisher | SEEd Medical Publishers |
| record_format | Article |
| series | Farmeconomia: Health Economics and Therapeutic Pathways |
| spelling | doaj.art-e33497e8f07c48b29e4047aeeb92b2482022-12-22T00:15:43ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2010-06-01112778210.7175/fe.v11i2.185167Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafilLuca Guidi0Mariano Alejandro Mignini1Health Outcomes research, Eli Lilly Italia S.p.A
Eli Lilly Intensive Care Regional Europe
This contribution is an attempt to estimate a range of Pulmonary Arterial Hypertension (PAH) prevalence in Italy using international literature and Italian drug market sales data and to evaluate the budget impact of the introduction of tadalafil among the actual drugs with specific indication for this pathology. The final epidemiological figure obtained shows a wide range of prevalence of PAH in Italy (900-3,000 cases). The introduction of tadalafil as PAH treatment should not cause a cost increase for the pharmaceutical budget considering that this new therapy will occupy essentially the patient segment actually treated with sildenafil and that it reduces, in a significant number of patients, the daily cost of PAH therapy through a stable, fixed dose, administration.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/185pulmonary arterial hypertensiontadalafilbudget impact |
| spellingShingle | Luca Guidi Mariano Alejandro Mignini Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil Farmeconomia: Health Economics and Therapeutic Pathways pulmonary arterial hypertension tadalafil budget impact |
| title | Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil |
| title_full | Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil |
| title_fullStr | Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil |
| title_full_unstemmed | Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil |
| title_short | Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil |
| title_sort | ipertensione arteriosa polmonare stima della casistica italiana e considerazioni sull impatto sul budget dell introduzione di tadalafil |
| topic | pulmonary arterial hypertension tadalafil budget impact |
| url | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/185 |
| work_keys_str_mv | AT lucaguidi ipertensionearteriosapolmonarestimadellacasisticaitalianaeconsiderazionisullimpattosulbudgetdellintroduzioneditadalafil AT marianoalejandromignini ipertensionearteriosapolmonarestimadellacasisticaitalianaeconsiderazionisullimpattosulbudgetdellintroduzioneditadalafil |